Go Pro
→ #1 Question to Ask Your Bank Today (From InvestorPlace) (Ad)tc pixel Free BVC Stock Alerts

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 13.60 -0.65 (-4.56%)
As of 07/17/2026 11:58 AM Eastern
Compare

BVC vs. TSTL, SPEC, AKR, ODX, and CNSL

Should you buy BATM Advanced Communications stock or one of its competitors? MarketBeat compares BATM Advanced Communications with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Omega Diagnostics Group (ODX), and Cambridge Nutritional Sciences (CNSL). These companies are all part of the "medical instruments & supplies" industry.

How does BATM Advanced Communications compare to Tristel?

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

In the previous week, Tristel had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 1 mentions for Tristel and 0 mentions for BATM Advanced Communications. Tristel's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Tristel Neutral
BATM Advanced Communications Neutral

21.6% of Tristel shares are owned by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are owned by institutional investors. 21.0% of Tristel shares are owned by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Tristel has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£49.54M3.70£6.54M£16.2423.49
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

Tristel has a net margin of 15.88% compared to BATM Advanced Communications' net margin of -14.90%. Tristel's return on equity of 23.64% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.88% 23.64% 9.89%
BATM Advanced Communications -14.90%-22.13%0.58%

Tristel has a beta of 0.339, suggesting that its share price is 66% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, suggesting that its share price is 25% less volatile than the broader market.

Summary

Tristel beats BATM Advanced Communications on 9 of the 12 factors compared between the two stocks.

How does BATM Advanced Communications compare to INSPECS Group?

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than BATM Advanced Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
INSPECS Group£191.70M0.56-£4.11M-£9.40N/A

BATM Advanced Communications has a beta of 0.754, suggesting that its share price is 25% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.607, suggesting that its share price is 61% more volatile than the broader market.

16.6% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 0.4% of INSPECS Group shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by company insiders. Comparatively, 19.6% of INSPECS Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

INSPECS Group has a consensus price target of GBX 60, indicating a potential downside of 38.78%. Given INSPECS Group's stronger consensus rating and higher probable upside, analysts plainly believe INSPECS Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, BATM Advanced Communications' average media sentiment score of 0.00 equaled INSPECS Group'saverage media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
INSPECS Group Neutral

INSPECS Group has a net margin of -2.67% compared to BATM Advanced Communications' net margin of -14.90%. INSPECS Group's return on equity of -6.07% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
INSPECS Group -2.67%-6.07%0.45%

Summary

INSPECS Group beats BATM Advanced Communications on 8 of the 14 factors compared between the two stocks.

How does BATM Advanced Communications compare to Akers Biosciences?

Akers Biosciences (LON:AKR) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Akers Biosciences has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Akers Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akers Biosciences£2.32M0.00N/A-£129.60N/A
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

16.6% of BATM Advanced Communications shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Akers Biosciences has a net margin of 0.00% compared to BATM Advanced Communications' net margin of -14.90%. Akers Biosciences' return on equity of 0.00% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Akers BiosciencesN/A N/A N/A
BATM Advanced Communications -14.90%-22.13%0.58%

In the previous week, Akers Biosciences' average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Akers Biosciences Neutral
BATM Advanced Communications Neutral

Summary

BATM Advanced Communications beats Akers Biosciences on 5 of the 8 factors compared between the two stocks.

How does BATM Advanced Communications compare to Omega Diagnostics Group?

BATM Advanced Communications (LON:BVC) and Omega Diagnostics Group (LON:ODX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

BATM Advanced Communications has a net margin of -14.90% compared to Omega Diagnostics Group's net margin of -51.15%. BATM Advanced Communications' return on equity of -22.13% beat Omega Diagnostics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Omega Diagnostics Group -51.15%-29.14%-10.53%

BATM Advanced Communications has a beta of 0.754, suggesting that its share price is 25% less volatile than the broader market. Comparatively, Omega Diagnostics Group has a beta of 3.85, suggesting that its share price is 285% more volatile than the broader market.

16.6% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 29.8% of Omega Diagnostics Group shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by insiders. Comparatively, 50.6% of Omega Diagnostics Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

BATM Advanced Communications has higher revenue and earnings than Omega Diagnostics Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Omega Diagnostics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
Omega Diagnostics Group£7.55M0.00-£3.17M-£0.01N/A

In the previous week, BATM Advanced Communications' average media sentiment score of 0.00 equaled Omega Diagnostics Group'saverage media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
Omega Diagnostics Group Neutral

Summary

BATM Advanced Communications beats Omega Diagnostics Group on 6 of the 10 factors compared between the two stocks.

How does BATM Advanced Communications compare to Cambridge Nutritional Sciences?

BATM Advanced Communications (LON:BVC) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

In the previous week, BATM Advanced Communications' average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
Cambridge Nutritional Sciences Neutral

BATM Advanced Communications has a beta of 0.754, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market.

16.6% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by company insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BATM Advanced Communications has higher revenue and earnings than Cambridge Nutritional Sciences. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
Cambridge Nutritional Sciences£8.06M0.48-£3.03M£0.602.71

Cambridge Nutritional Sciences has a net margin of 16.94% compared to BATM Advanced Communications' net margin of -14.90%. Cambridge Nutritional Sciences' return on equity of 12.15% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

Summary

Cambridge Nutritional Sciences beats BATM Advanced Communications on 6 of the 11 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

Export
MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£46.25M£2.82B£6.88B£2.78B
Dividend Yield3.52%1.92%2.67%6.15%
P/E Ratio-3.2417.4227.17368.19
Price / Sales0.38106.37529.4184,555.32
Price / Cash2.12146.5451.4627.89
Price / Book0.582.5110.697.53
Net Income-£278.26K£99.80M£3.59B£5.89B
7 Day Performance-6.21%-0.38%-2.19%5.78%
1 Month Performance-1.81%3.68%1.64%4.65%
1 Year Performance-11.11%-4.06%25.60%61.87%

BATM Advanced Communications Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 13.60
-4.6%		N/A-11.7%£46.25M£123.20MN/A980
TSTL
Tristel
N/AGBX 390
-0.6%		N/A-6.3%£187.19M£49.54M24.01208
SPEC
INSPECS Group
N/AGBX 97
flat		GBX 60
-38.1%		+124.8%£105.90M£191.70MN/A1,673
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32MN/A120
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55MN/A91

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:BVC) was last updated on 7/18/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The only metrics you should watch as a day trader.
Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...
The TradingPub | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
#1 Question to Ask Your Bank Today
Elon Musk's new banking platform is paying up to 15 times the national average interest rate while insuring de...
InvestorPlace | Sponsoredtc pixel
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...
Chaikin Analytics | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
URGENT Dollar Reset Warning for Monday
A 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...
Golden Portfolio | Sponsoredtc pixel